Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial (Oct, 10.1038/s41391-021-00465-7, 2021) Correction

cited authors

  • Penson, David F.; Armstrong, Andrew J.; Concepcion, Raoul S.; Agarwal, Neeraj; Olsson, Carl A.; Karsh, Lawrence I.; Dunshee, Curtis J.; Duggan, William; Shen, Qi; Sugg, Jennifer; Haas, Gabriel P.; Higano, Celestia S.

authors

Publication Date

  • November 30, 2021

webpage

published in

category

start page

  • 597

end page

  • 597

volume

  • 25

issue

  • 3